Potential predictors of chemotherapy response in ovarian cancer--how do we define chemosensitivity? (Q79206801)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027070%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Potential predictors of chemotherapy response in ovarian cancer--how do we define chemosensitivity? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027070%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027070%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

John O'Leary

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027070%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

O'Toole SA

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027070%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Sheppard BL

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027070%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

McGuinness EP

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027070%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

D'Arcy T

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027070%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Bonnar J

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027070%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

5 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027070%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027070%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027070%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027070%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

345-351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027070%20AND%20SRC:MED&resulttype=core&format=json

Estimates of the worldwide incidence of 25 major cancers in 1990.

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Induction of angiogenesis during the transition from hyperplasia to neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Tumor-related angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

The role of vascular endothelial growth factor in pathological angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

The relevance of angiogenesis in benign and malignant epithelial tumors of the ovary: a quantitative histologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Vascular endothelial growth factor expression in early stage ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

VEGF, VEGFR-1, VEGFR-2, microvessel density and endothelial cell proliferation in tumours of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Prognostic significance of tumor angiogenesis in epithelial ovarian cancer: in association with transforming growth factor beta and vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with high mitotic activity and high FIGO stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

The influence of microvessel density on ovarian carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Expression of vascular endothelial growth factor related to 72-kilodalton metalloproteinase immunostaining in patients with serous ovarian tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

CD31 expression in benign, borderline, and malignant epithelial ovarian tumors: an immunohistochemical and serological analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Prognostic significance of tumor angiogenesis in epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Prognostic Value of Microvessel Quantitation in Cisplatin Treated Figo 3 and 4 Ovarian Cancer Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Amplification of the mdr1-gene is uncommon in recurrent ovarian carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Targeting HIF-1 for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

Prospective on ovarian cancer: why prevent?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.039

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2006.08.039

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17027070%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference